NCT02766699 2025-06-03
CerebralEDV
Engeneic Pty Limited
Phase 1 Completed
Clinical Trials
10 trialsNCT02392078 2025-04-24
LAANTERN
Monteris Medical
Completed
NCT02846038 2024-07-25
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
St. Jude Children's Research Hospital
Completed
NCT01651078 2024-04-15
LAASR
Monteris Medical
Completed
NCT02389855 2024-04-12
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Monteris Medical
Completed
NCT04346472 2020-04-16
SPECIFY
University Hospital, Montpellier
Completed
NCT00272350 2019-12-05
ZD6474 to Treat Advanced Brain Cancer in Patients
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00201903 2017-04-06
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
Completed
NCT00995007 2016-03-29
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00108069 2015-11-05
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Completed